Advances in mesenchymal stromal cell therapy in the management of Crohn's disease. (Q47287228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

title

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Hajir Ibraheim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Chiara Giacomini

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Zain Kassam

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Francesco Dazzi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

language of work or name

1 reference

2 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Gastroenterology & Hepatology

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

141-153

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and Natural History of Inflammatory Bowel Diseases

8 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Vedolizumab as induction and maintenance therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

CD4(+) T-cell subsets in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Imbalances of CD4(+) T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Fine-mapping inflammatory bowel disease loci to single-variant resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cell homing: the devil is in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

From isolation to implantation: a concise review of mesenchymal stem cell therapy in bone fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-γ Modified Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cells attenuate liver fibrosis by suppressing Th17 cells - an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+)CD28(-) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cells induce apoptosis of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mucosally transplanted mesenchymal stem cells stimulate intestinal healing by promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Fistulizing Crohn's disease: Diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Morphological characterisation of Crohn's disease fistulae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

CD4+CD161+ T lymphocytes infiltrate Crohn's disease-associated perianal fistulas and are reduced by anti-TNF-α local therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17474124.2018.1393332

10.1080/17474124.2018.1393332

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29096549%20AND%20SRC:MED&resulttype=core&format=json